SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-18-001510
Filing Date
2018-05-01
Accepted
2018-05-01 08:42:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da110042007_04302018.htm SC 13D/A 201486
2 JOINT FILING AND SOLICITATION AGREEMENT ex991to13da110042007_043018.htm EX-99.1 14632
3 FORM OF INDEMNIFICATION AGREEMENT ex992to13da110042007_043018.htm EX-99.2 13550
4 FORM OF COMPENSATION AGREEMENT ex993to13da110042007_043018.htm EX-99.3 8877
5 POWERS OF ATTORNEY ex994to13da110042007_043018.htm EX-99.4 25212
  Complete submission text file 0000921895-18-001510.txt   265361
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Subject) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-57907 | Film No.: 18793341
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A